STOCK TITAN

HAIAF shareholders back SPAC extension with new monthly deposits

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Healthcare AI Acquisition Corp. reported that shareholders approved extending the deadline to complete a business combination from October 14, 2025 on a month-to-month basis until October 14, 2026. For each monthly extension, the company will deposit $0.10 per non-redeemed public share into its trust account. In connection with the meeting, 23,033 shares were redeemed for approximately $292,422.64, or about $12.69 per share, to be paid from the trust. After these redemptions, the company has 5,520,077 Class A ordinary shares and one Class B share outstanding, and approximately $1,643,828.35 remains in its trust account.

Positive

  • None.

Negative

  • None.

Insights

SPAC deadline extended with a smaller trust and modest redemptions.

Healthcare AI Acquisition Corp. obtained shareholder approval to extend its business combination deadline month-to-month to October 14, 2026. Each month, it must contribute $0.10 per non-redeemed public share into the trust, which ties the cost of time directly to the remaining public float.

At the meeting, 23,033 shares were redeemed for about $292,422.64, or $12.69 per share, paid from the trust. After these redemptions, the trust balance stands at approximately $1,643,828.35 with 5,520,077 Class A ordinary shares and one Class B share outstanding, so any future business combination would be structured around this smaller cash pool unless additional capital is raised.

The month-to-month extension framework allows the company to continue pursuing a transaction through October 14, 2026, while the recurring deposits modestly replenish the trust. Actual outcomes will depend on whether additional shareholders redeem in future extensions and whether a suitable business combination is identified and approved.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 19, 2025 (October 10, 2025)

 

HEALTHCARE AI ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

001-41145

98-1585450

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

418 Broadway #6434

Albany NY 12207

(Address of principal executive offices, including zip code)

 

(917) 446-0469

Registrant’s telephone number, including area code: 

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant

 

HAIUF

 

OTC Market Group, Inc,

 

 

 

 

 

Class A Ordinary Share, par value $0.0001 per share

 

HAIAF

 

OTC Market Group, Inc,

 

 

 

 

 

Warrant, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share

 

HAIWF

 

OTC Market Group, Inc,

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 Item 8.01. Other Events.

 

As previously reported, on October 10, 2025, Healthcare AI Acquisition Corp. (the “Company”) held its general annual meeting (the “Meeting”).  At the Meeting, the proposal was approved for the Company to extend the date by which it has to complete a business combination from October 14, 2025 on a month-to-month basis until October 14, 2026 (each month so extended, the “Extended Date”), by depositing into the trust account $0.10 per non-redeemed public share for each monthly extension deposited into the Company’s trust account (the “Trust Account”), held by Continental Stock Transfer & Trust Company.

 

In connection with the shareholders’ vote at the Meeting, 23,033 shares were tendered for redemption. As a result, approximately $292,422.64 (approximately $ 12.69 per share) will be removed from the Company’s Trust Account to pay such holders, without taking into account additional allocation of payments to cover any tax obligation of the Company since that date. Following redemptions, the Company will have 5,520,077 Class A Shares outstanding, and one Class B Share outstanding, and approximately $1,643,828.35 will remain in the Company’s Trust Account.

 

 

2

 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

HEALTHCARE AI ACQUISITION CORP.

 

 

 

 

Dated: November 19, 2025 

By:

/s/ Jiande Chen

 

 

Name: 

Jiande Chen

 

 

Title:

Chief Executive Officer

 

 

 

3

FAQ

What did Healthcare AI Acquisition Corp. (HAIAF) shareholders approve at the recent meeting?

Shareholders approved extending the deadline for Healthcare AI Acquisition Corp. to complete a business combination from October 14, 2025 on a month-to-month basis until October 14, 2026. Each month of extension requires a deposit of $0.10 per non-redeemed public share into the company’s trust account.

How many Healthcare AI Acquisition Corp. shares were redeemed and for how much?

In connection with the meeting, 23,033 shares of Healthcare AI Acquisition Corp. were tendered for redemption. These redemptions will result in payments of approximately $292,422.64 in total, or about $12.69 per share, from the trust account.

What is the remaining trust account balance for Healthcare AI Acquisition Corp. after redemptions?

After paying holders of the 23,033 redeemed shares, approximately $1,643,828.35 will remain in Healthcare AI Acquisition Corp.’s trust account held by Continental Stock Transfer & Trust Company.

How many Healthcare AI Acquisition Corp. shares are outstanding after the latest redemptions?

Following the redemptions, Healthcare AI Acquisition Corp. has 5,520,077 Class A ordinary shares outstanding and one Class B share outstanding.

How will the monthly extension deposits work for Healthcare AI Acquisition Corp.?

For each month that Healthcare AI Acquisition Corp. extends its business combination deadline up to October 14, 2026, it will deposit $0.10 per non-redeemed public share into the trust account, increasing the cash backing remaining public shares.

On which market are Healthcare AI Acquisition Corp.’s securities quoted?

Healthcare AI Acquisition Corp. has units, Class A ordinary shares, and warrants quoted on OTC Market Group, Inc. under the symbols HAIUF (units), HAIAF (Class A ordinary shares), and HAIWF (warrants).